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Abstract 19 
Obesity is an important health problem worldwide. Adipose tissue acts as an 20 
endocrine organ that secretes various bioactive substances, called adipokines, 21 
including pro-inflammatory biomarkers such as TNF-α, IL-6, leptin and C-reactive 22 
protein (CRP) and anti-inflammatory molecules such as adiponectin. The 23 
deregulated production of adipokines in obesity is linked to the pathogenesis of 24 
various disease processes and monitoring their variation is critical to understand 25 
metabolic diseases. 26 
The aim of this study was to determine the plasma concentration of adipokines in 27 
healthy subjects by multiplexed measurements and the effect of anticoagulants on 28 
their levels. 29 
Plasma samples from 10 healthy donors were collected in two different 30 
anticoagulants (sodium citrate or heparin).  31 
All markers, excluding TNF-α, showed significantly higher concentrations in 32 
heparinized compared to citrate plasma. However, levels of adipokines in different 33 
plasma samples highly correlated for most of these markers. 34 
We reported that different anticoagulants used in the preparation of the plasma 35 
samples affected the measurements of some adipokines. The importance of the 36 
present results in epidemiology is relevant when comparing different studies in 37 
which blood samples were collected with different anticoagulants. 38 
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1. Introduction 41 
Adipokines are defined as cell signaling mediators secreted by the adipose tissue. 42 
They have both pro-inflammatory and anti-inflammatory activities, and the 43 
imbalance between the different factors secreted by adipose tissue contributes to 44 
metabolic dysfunction. [1]. When adipocyte dysfunction is developed as a result of 45 
adipose tissue expansion, the deregulation of adipokine levels can produce several 46 
effects on inflammatory responses, thereby contributing to the initiation and 47 
progression of obesity-induced metabolic and cardiovascular complications [1]. 48 
Therefore, further elucidation of the functions and mechanisms of key adipokines 49 
will lead to a better understanding of the pathogenesis of obesity-linked disorders.  50 
Adipokines are involved in the regulation of metabolism and insulin sensitivity. 51 
Moreover, inflammation and blood concentrations of various adipokines are 52 
associated with obesity, metabolic and cardiovascular diseases. It is, therefore, 53 
emerging that serum adipokine levels may serve as biomarkers of obesity-related 54 
illnesses [2]. 55 
Recent papers demonstrated the effect of anticoagulants on multiplexed 56 
measurement of cytokines/chemokines in healthy subjects [3-7], highlighting the 57 
importance of sample preparation in biomarkers measurements in plasma. The 58 
Luminex multiplex platform system is a highly efficient fluorescent (or magnetic) 59 
bead-based capture/detection sandwich immunoassay that allows for 60 
measurements of multiple analytes simultaneously in a single reaction with small 61 
sample volumes [8, 9]. This technology can measure up to 100 different analytes 62 
using as little as 50 µl sample volume, making it an assay very useful in clinical 63 
trials or epidemiology studies, especially when volumes are limited. 64 
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The aim of this study was to evaluate the effect of two different anticoagulants 65 
(lithium heparin (LiEP) and sodium citrate (NaCitr)) on the levels of adipokines in 66 
plasma collected from 10 healthy subjects. Multiplex microbead immunoassay was 67 
performed for measuring IL-6, TNF-α and leptin while adiponectin and C-reactive 68 
protein (CRP) were measured as a single measurement. 69 
 70 
2. Materials and Methods 71 
2.1 Samples 72 
Samples were obtained concurrently from 10 healthy donors. Twenty milliliters of 73 
peripheral venous blood were drawn into vacutainer tubes containing two 74 
different anticoagulants (LiEp or NaCitr). Samples were centrifuged immediately 75 
after the blood withdrawal, and plasma was analysed within 1 hour. Cells were 76 
removed from plasma by centrifugation for 15 minutes at 2,000 x g at room 77 
temperature. Written informed consent was achieved from all subjects. The study 78 
protocol was approved by the ethics committee of the Fondazione IRCCS (Istituto 79 
per la Ricerca e la Cura del Cancro, National Institute for Research and Treatment 80 
of Cancer) Istituto Nazionale dei Tumori (Milan, Italy).  81 
Aliquots of the samples were stored at -80⁰C and analysed ten days later. 82 
 83 
2.2 Experimental measurements  84 
The adipokine analysis was performed with the Luminex technology, which 85 
combines the principle of a sandwich immunoassay with fluorescent bead-based 86 
technology. In this way, individual and multiplex analysis of different analytes in a 87 
single microwell plate are allowed [10]. Capture antibodies directed against the 88 
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biomarker of interest are covalently coupled to fluorescently dyed magnetic 89 
microspheres, each with a different color code or spectral address to allow 90 
discrimination of individual tests within a multiplex suspension. Coupled beads 91 
react with the sample containing the analyte of interest. After a series of washes to 92 
remove unbound protein, a biotinylated detection antibody is added to create a 93 
sandwich complex. The final detection complex is formed by the addition of 94 
streptavidin-phycoerythrin (SA-PE) conjugate. Phycoerythrin serves as a 95 
fluorescent indicator.  96 
The assay for human IL-6, TNF-α, leptin, adiponectin (Bio-Rad Laboratories, 97 
Hercules California, USA) and CRP (Merk Millipore, Darmstadt, Germany) was 98 
carried out on fresh plasma samples using 96-well microplates accordingly to the 99 
recommendations of manufacturers. The contents of each well were moved into 100 
the Bio-Plex 100 System array reader (Bio-Rad Laboratories Bio-Rad Laboratories, 101 
Hercules California, USA), which identifies and quantifies each specific reaction 102 
based on bead color and fluorescent signal intensity. The data were finally 103 
processed using Bio-Plex Manager software (version 6.1) using five-parametric 104 
curve fitting and converted in pg/ml. 105 
 106 
2.3 Statistical analyses 107 
All results are showed as mean ± standard deviation (SD). Data were compared by 108 
nonparametric analyses with Wilcoxon’s matched pairs test, in which the median 109 
was used to calculate significant differences. Spearman correlation coefficients 110 
were calculated to investigate the correlation between measurements obtained 111 
with the two anticoagulants. All statistical analyses were performed using the 112 
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statistical software GraphPad Prism 5, version 5.04 (GraphPad Software, San 113 
Diego, CA). 114 
When measurements were below the lower limit of detection (LLD, <5% of 115 
measurements), we assigned a value equal to the midpoint between the LLD and 116 
zero. 117 
 118 
3. Results and Discussion 119 
Significant differences in the measurements of all adipokines, except TNF-α, were 120 
observed in plasma samples collected in different anticoagulants (Fig. 1). IL-6, 121 
leptin, adiponectin and CRP showed a significantly higher concentration in heparin 122 
plasma compared to citrate.  123 
However, despite these differences in absolute levels, the measurements of all 124 
adipokines were highly correlated each other, except for TNF-α (Fig. 2). We can 125 
speculate that, even though the measured levels differ, the same variation between 126 
individuals can be detected, as demonstrated by the significant correlations.  127 
TNF-α measurements differed from the other mediators both with regard to the 128 
effect of anticoagulant and the lack of correlation between the levels in the paired 129 
samples. These differences could be due to the very low levels, quite undetectable, 130 
of this cytokine in our samples. To explain these results we performed also an 131 
ELISA assay for TNF-α on the same samples: by this way we confirmed the absence 132 
of significant differences in the levels of TNF-α in plasma samples obtained using 133 
different anticoagulants. On the contrary, correlation analysis of ELISA results 134 
obtained with the two anticoagulants was statistically significant (r = 0.811; p = 135 
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0.004), confirming the results obtained with the other adipokines (data not 136 
shown).  137 
We carried out this study with explorative purposes only on ten subjects, with the 138 
aim to understand if the cross-comparison of levels or profiles of adipokines 139 
performed in different anticoagulants (e.g. results collected from various studies) 140 
could be performed. 141 
Adipokines are involved in the regulation of metabolism, insulin sensitivity, and 142 
inflammation and serum concentrations of various adipokines are associated with 143 
obesity, metabolic and cardiovascular diseases [1, 2]. It has been therefore 144 
hypothesized that serum adipokine levels may serve as predictors of obesity-145 
related diseases or the individual disease outcomes [11].  146 
Our study focused the attention on the measurement of five adipokines. 147 
Anticoagulants effect on IL-6 and TNF-α measurements has been already described 148 
in recent papers [3-6], while only a few of them described the effect on leptin [3, 5] 149 
or CRP [5], and none, to our knowledge, reported anticoagulants effect on 150 
adiponectin measurement. However, the importance of such a study is underlined 151 
by the proposal of using adiponectin as a clinical biomarker for several diseases 152 
[12]. Lifestyle modification with visceral fat reduction combined with targeted 153 
therapeutic interventions designed to improve adiponectinemia seem to be 154 
potential clinically useful strategies to prevent obesity-related diseases, including 155 
type 2 diabetes, cardiovascular diseases and malignancies [12]. 156 
Significant differences observed between different plasma samples in IL-6, leptin 157 
and CRP levels were not in agreement with previous data reported by Biancotto et 158 
al. [5], however, we measured analyte levels in fresh sample while they performed 159 
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the assay on frozen specimens. When we did the same test on frozen samples, 160 
statistically significant differences between plasma samples (LiEp vs. NaCitr) were 161 
no more observed for IL-6 measurements but were still significant for leptin 162 
measurements (p=0.002, Supplementary Materials Fig. S1). However, we observed 163 
a significant difference between fresh and frozen plasma samples with Li Ep for IL-164 
6 measurements (p<0.001, Fig. S1) and between fresh and frozen plasma samples 165 
both with LiEp and NaCitr for leptin measurements (p=0.002, Fig. S1). Moreover, 166 
these statistically significant results always showed a significant correlation (IL-6 167 
LiEp fresh vs. frozen r=0.988, p<0.0001; Leptin LiEp fresh vs. frozen r=1, 168 
p<0.0001; Leptin NaCitr fresh vs. frozen r=0.939, p<0.002; Supplementary 169 
Materials Fig. S2). Previous papers on anticoagulant effect on cytokine 170 
measurements often showed undetectable levels of IL-6, TNF-α or leptin, probably 171 
because samples were stored at -80⁰C for a different time and affected by multiple 172 
freeze-thawing cycles [3, 5, 6].  173 
We dedicated our attention only at plasma samples, but differences between 174 
plasma and serum cytokine measurements have been also described. However, 175 
results are often discordant: for many analytes, high correlation were observed 176 
between serum and plasma levels even when absolute levels differed. In fact, the 177 
removal of fibrinogen, platelets and other circulating proteins from the plasma 178 
during serum preparation could influence the presence or detection of an analyte. 179 
Also during the cascade of coagulation, activation of cellular elements can release 180 
inflammatory mediators, that may affect cytokine levels. This kind of information 181 
are available for IL-6 and TNF-α [3-6], leptin [3, 5] or CRP [5], but are not available 182 
for adiponectin. Possible differences between serum and plasma samples should 183 
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be taken into consideration also when measuring adipokine levels and further 184 
evaluations are needed. 185 
We used Luminex multiplex bead-based technology, with the antibody kits 186 
purchased from Bio-Rad or Merk (see Section 2). Previous studies compared the 187 
performance of multiplex microbead assays between various vendors, and it was 188 
noted that the consistency between the vendors was high only for some analytes 189 
[13, 14]. Though our conclusions are broadly applicable, specific care must be 190 
taken when other kits or suppliers are used. 191 
 192 
4. Conclusions  193 
Our results emphasize, as already demonstrated for cytokines/chemokines [3-7], 194 
the need to consider sample collection methods carefully when a study requires 195 
measurement of adipokines in the peripheral blood. Cross comparison of levels or 196 
profiles of adipokines performed in different anticoagulants should be avoided. 197 
However, we observed a correlation between levels in plasma samples obtained 198 
with different anticoagulants, and a possible solution might be the normalization 199 
of values from one type of samples to an alternative type. Despite this possibility, 200 
Jung and Wu demonstrated that this kind of conversion is complicated, and 201 
calculations based on correlation analyses alone are not sufficient [15]. 202 
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